Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, announced today ...

The University event for early-career researchers and creators to present their work celebrated its 10th anniversary.

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Preclinical Psoriasis Data Presented at SID Annual Meeting On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation ...

Their research findings and creative works are presented at international conferences, local symposia, and community events. From scholarly lectures to TED-style talks, from academic posters to ...

The poster is scheduled for presentation on May 31, 2025 ... progress and results of our preclinical and clinical studies and our research and development programs, (ii) our ability to advance product ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of six posters, including one oral ...

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of six posters ...

The presentation highlights collaborative research contributing to PanGIA’s AI-driven, urine-based diagnostic platform. The work integrates biomolecular pattern analysis and machine learning to ...

based Capsida Biotherapeutics (Capsida) has announced its slate of seven scientific presentations, three oral and four in poster form, that have been ... and Ophthalmology Preclinical Research, is ...

The Undergraduate Research Symposium was held on Thursday at the Illini Union in Illini Rooms A, B and C. It featured a combination of oral and poster presentations on topics ranging from computer ...